Literature DB >> 17109992

Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung.

Yong-Woo Choi1, Jin Soo Choi, Long Tai Zheng, Yun Jeong Lim, Hyoung Kyu Yoon, Yeul Hong Kim, Young-Pil Wang, Young Lim.   

Abstract

Genomic alterations have been identified in lung cancer tissues and reported in numerous studies. To analyze genomic aberrations in lung cancer patients, we used array comparative genomic hybridization (array CGH) in 14 squamous cell lung carcinoma (SqC) tissues. Copy number gain and loss in chromosomal regions were detected, and the corresponding genes were confirmed by real time PCR. Several frequently altered loci, including gain of 3q (36% of samples), were found. The most frequently identified losses were found at 14q32.33 (21% of samples). The relative degree of chromosomal change was analyzed using log2 ratios. High-level DNA amplifications (>0.8 log2 ratio) were detected at 20 regions in 1p, 2q, 3q, 4q, 6q, 7p, 8q, 9p, 10q, 12q, 14q and 19p. We found that the fold change levels were highest at EVI1 (3q26.2), LPP (3q27-28) and FHF-1 (3q28) gene loci. Our results show that array CGH is a useful tool for identification of gene alteration in lung cancer, and that the above-mentioned genes might represent potential candidate genes for pathogenesis and diagnosis of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109992     DOI: 10.1016/j.lungcan.2006.09.018

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  29 in total

1.  Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors.

Authors:  Emilie A Bard-Chapeau; Justin Jeyakani; Chung H Kok; Julius Muller; Belinda Q Chua; Jayantha Gunaratne; Arsen Batagov; Piroon Jenjaroenpun; Vladimir A Kuznetsov; Chia-Lin Wei; Richard J D'Andrea; Guillaume Bourque; Nancy A Jenkins; Neal G Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

Review 2.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

3.  Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung.

Authors:  Jing Wang; Jun Qian; Megan D Hoeksema; Yong Zou; Allan V Espinosa; S M Jamshedur Rahman; Bing Zhang; Pierre P Massion
Journal:  Clin Cancer Res       Date:  2013-08-01       Impact factor: 12.531

4.  EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.

Authors:  Emilie A Bard-Chapeau; Jayantha Gunaratne; Pankaj Kumar; Belinda Q Chua; Julius Muller; Frederic A Bard; Walter Blackstock; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

5.  Array CGH reveals genomic aberrations in human emphysema.

Authors:  Jin Soo Choi; Woon Jeong Lee; Seung Ho Baik; Hyoung Kyu Yoon; Kweon-Haeng Lee; Yeul Hong Kim; Young Lim; Young-Pil Wang
Journal:  Lung       Date:  2009-04-08       Impact factor: 2.584

6.  Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP.

Authors:  Thomas Gp Grunewald; Saskia M Pasedag; Elke Butt
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

7.  MicroRNA expression differentiates histology and predicts survival of lung cancer.

Authors:  Maria Teresa Landi; Yingdong Zhao; Melissa Rotunno; Jill Koshiol; Hui Liu; Andrew W Bergen; Maurizia Rubagotti; Alisa M Goldstein; Ilona Linnoila; Francesco M Marincola; Margaret A Tucker; Pier Alberto Bertazzi; Angela C Pesatori; Neil E Caporaso; Lisa M McShane; Ena Wang
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

8.  Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis.

Authors:  Vitalyi Senyuk; Yunyuan Zhang; Yang Liu; Ming Ming; Kavitha Premanand; Lan Zhou; Ping Chen; Jianjun Chen; Janet D Rowley; Giuseppina Nucifora; Zhijian Qian
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

9.  SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Authors:  Adam J Bass; Hideo Watanabe; Craig H Mermel; Soyoung Yu; Sven Perner; Roel G Verhaak; So Young Kim; Leslie Wardwell; Pablo Tamayo; Irit Gat-Viks; Alex H Ramos; Michele S Woo; Barbara A Weir; Gad Getz; Rameen Beroukhim; Michael O'Kelly; Amit Dutt; Orit Rozenblatt-Rosen; Piotr Dziunycz; Justin Komisarof; Lucian R Chirieac; Christopher J Lafargue; Veit Scheble; Theresia Wilbertz; Changqing Ma; Shilpa Rao; Hiroshi Nakagawa; Douglas B Stairs; Lin Lin; Thomas J Giordano; Patrick Wagner; John D Minna; Adi F Gazdar; Chang Qi Zhu; Marcia S Brose; Ivan Cecconello; Ulysses Ribeiro; Suely K Marie; Olav Dahl; Ramesh A Shivdasani; Ming-Sound Tsao; Mark A Rubin; Kwok K Wong; Aviv Regev; William C Hahn; David G Beer; Anil K Rustgi; Matthew Meyerson
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

10.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.